MRC1 and Inherited cancer-predisposing syndrome: Although MMR/MSI status was not systematically assessed in our cohort, these data underscore the need for routine MMR testing in this subtype, given its relevance for identifying hereditary cancer syndromes and for selecting patients who may benefit from immunotherapy [19,20].